ALEXANDRA APODACA: Open Payments
NPI 1790344331 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $102 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Organon LLC | 5 | $53 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Krystal Biotech Inc | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| KYOWA KIRIN, INC. | 1 | $27 |
| ABBVIE INC. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
Products named: OPZELURA, DUPIXENT, NEMLUVIO, VYJUVEK, Odomzo, POTELIGEO, SKYRIZI, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
